Related Experiment Video
Updated: May 15, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
Suppression of miRNA-708 by polycomb group promotes metastases by calcium-induced cell migration
Seongho Ryu1, Kevin McDonnell, Hyejin Choi
1Department of Cardiothoracic Surgery, Weill Cornell Medical College of Cornell University, New York, NY 10065, USA.
Abstract:
The progression of cancer to metastatic disease is a major cause of death. We identified miR-708 being transcriptionally repressed by polycomb repressor complex 2-induced H3K27 trimethylation in metastatic breast cancer. miR-708 targets the endoplasmic reticulum protein neuronatin to decrease intracellular calcium level, resulting in reduction of activation of ERK and FAK, decreased cell migration, and impaired metastases. Ectopic expression of neuronatin refractory to suppression by miR-708 rescued cell migration and metastasis defects. In patients with breast cancer, miR-708 expression was decreased in lymph node and distal metastases, suggesting a metastasis-suppressive role. Our findings uncover a mechanistic role for miR-708 in metastasis and provide a rationale for developing miR-708 as a therapeutic agent against metastatic breast cancer.
Insights
MicroRNA-708 (miR-708) suppresses breast cancer metastasis by targeting neuronatin, reducing cell migration and invasion. Lower miR-708 levels correlate with metastasis in patients, indicating its therapeutic potential.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Metastatic breast cancer remains a leading cause of cancer-related mortality.
- Understanding the molecular mechanisms driving metastasis is crucial for developing effective therapies.
Purpose of the Study:
- To investigate the role of microRNA-708 (miR-708) in breast cancer metastasis.
- To elucidate the regulatory mechanisms and downstream targets of miR-708 in the context of metastasis.
Main Methods:
- Analysis of miR-708 expression in breast cancer tissues.
- Investigating the role of Polycomb Repressor Complex 2 (PRC2) in miR-708 repression.
- Identifying miR-708 targets and their functional consequences on cell migration and metastasis.
- In vitro and in vivo models of breast cancer metastasis.
Main Results:
- miR-708 is transcriptionally repressed by PRC2-mediated H3K27 trimethylation in metastatic breast cancer.
- miR-708 directly targets neuronatin, decreasing intracellular calcium levels.
- Reduced neuronatin levels impair activation of ERK and FAK, leading to decreased cell migration and metastasis.
- Ectopic expression of miR-708 suppressed metastasis, while neuronatin overexpression rescued these defects.
- miR-708 expression is significantly decreased in lymph node and distal metastases of breast cancer patients.
Conclusions:
- miR-708 acts as a metastasis suppressor in breast cancer by regulating the neuronatin-calcium-ERK/FAK pathway.
- PRC2-mediated repression of miR-708 contributes to breast cancer progression and metastasis.
- miR-708 represents a potential therapeutic target for combating metastatic breast cancer.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic cells are...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Cell Migration through Invadopodia
